IBKS No3 SPAC (225430) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.003x

Based on the latest financial reports, IBKS No3 SPAC (225430) has a cash flow conversion efficiency ratio of -0.003x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-79.11 Million ≈ $-53.61K USD) by net assets (₩26.67 Billion ≈ $18.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is IBKS No3 SPAC worth for the company's overall valuation and market capitalisation.

IBKS No3 SPAC - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how IBKS No3 SPAC's cash flow conversion efficiency has evolved over time, based on yearly financial data.

IBKS No3 SPAC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of IBKS No3 SPAC ranked by their cash flow conversion efficiency. Explore earnings quality score of IBKS No3 SPAC to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Ankit Metal & Power Limited
NSE:ANKITMETAL
-0.018x
Siti Networks Limited
NSE:SITINET
-0.072x
Pheton Holdings Ltd Class A Ordinary Shares
NASDAQ:PTHL
-0.599x
Oculus VisionTech Inc
V:OVT
-0.001x
International Prospect Ventures Ltd
V:IZZ
-0.357x
QMC Quantum Minerals Corp
V:QMC
0.001x
Greenwave Technology Solutions Inc. Common Stock
NASDAQ:GWAV
-0.017x
Constellation Technologies Ltd
AU:CT1
0.038x

Annual Cash Flow Conversion Efficiency for IBKS No3 SPAC (2016–2025)

The table below shows the annual cash flow conversion efficiency of IBKS No3 SPAC from 2016 to 2025. View IBKS No3 SPAC (225430) stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩28.27 Billion
≈ $19.16 Million
₩-1.75 Billion
≈ $-1.19 Million
-0.062x +0.76%
2024-12-31 ₩32.62 Billion
≈ $22.10 Million
₩-2.04 Billion
≈ $-1.38 Million
-0.062x -253.12%
2023-12-31 ₩35.48 Billion
≈ $24.04 Million
₩1.45 Billion
≈ $980.06K
0.041x +1686.79%
2022-12-31 ₩36.33 Billion
≈ $24.62 Million
₩-93.32 Million
≈ $-63.24K
-0.003x -104.52%
2021-12-31 ₩39.91 Billion
≈ $27.04 Million
₩2.27 Billion
≈ $1.54 Million
0.057x +154.79%
2020-12-31 ₩40.77 Billion
≈ $27.63 Million
₩909.18 Million
≈ $616.14K
0.022x +176.93%
2019-12-31 ₩24.19 Billion
≈ $16.40 Million
₩-701.24 Million
≈ $-475.22K
-0.029x -156.77%
2018-12-31 ₩23.83 Billion
≈ $16.15 Million
₩1.22 Billion
≈ $824.56K
0.051x +1058.34%
2017-12-31 ₩8.48 Billion
≈ $5.74 Million
₩-45.15 Million
≈ $-30.60K
-0.005x +35.53%
2016-12-31 ₩8.46 Billion
≈ $5.73 Million
₩-69.90 Million
≈ $-47.37K
-0.008x --

About IBKS No3 SPAC

KQ:225430 Korea Asset Management
Market Cap
$2.64 Million
₩3.89 Billion KRW
Market Cap Rank
#29750 Global
#2096 in Korea
Share Price
₩698.00
Change (1 day)
+2.35%
52-Week Range
₩340.00 - ₩3035.00
All Time High
₩4900.00
About

KMPHARMACEUTICAL Co.,Ltd. engages in the manufacture, wholesale, and retail of oral care, beauty care, and other daily necessities in South Korea and internationally. The company offers toothpastes, toothbrushes, cosmetics, masks, hand cream, toothbrush and toothpaste, kids toothbrush, and baby finger toothbrush sets. It also provides children's safety gargles, baby and light wipes, wet wipes, an… Read more